G. B. Migliori (Tradate, Italy), G. Ferrara (Terni, Italy)
Molecular surveillance of multi-drug resistant tuberculosis in Europe
I. Devaux, D. Falzon, K. Kremer, D. Van Sooligen (Saint Maurice, France; Bilthoven, Netherlands)
|   |
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Y. S. Shim, H. J. Kim, S. M. Lee, J. J. Yim, C. G. Yoo, Y. W. Kim, S. K. Han (Seoul, Republic Of Korea)
| |
The experience of additional treatment of MDR-TB patients using autologous mesenchymal stem cells
I. A. Vasilyeva, A. G. Konoplyannikov, V. V. Erokhin, A. F. Tsyb, V. I. Chukanov, A. A. Danilenko (Moscow, Obninsk, Russian Federation)
| |
Risk of mortality of extensively drug-resistant tuberculosis (XDR-TB) in Italy and Germany
G. B. Migliori, J. Ortmann, E. Girardi, G. Besozzi, C. Lange, D. M. Cirillo, M. Ferrarese, G. De Iaco, A. Gori, M. C. Raviglione (Tradate, Rome, Sondalo, Milano, Brescia, Italy; Bad Lippspringe, Borstel, Germany; Geneva, Switzerland)
|  |
Multidrug resistant tuberculosis in the Torres Strait
G. Simpson, T. Knight, S. Vincent, C. Gilpin (Queensland, Australia)
| |
Treatment outcomes for XDR TB patients with surgery
G. Dravniece, K. Cain, V. Leimane, V. Riekstina, T. Holtz (Riga, Latvia; Atlanta, United States Of America)
| |
Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting
K. M. Korde, J. P. Watson (Leeds, West Yorkshire, United Kingdom)
| |
Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
S. Blaas, R. Mütterlein, J. Weig, A. Neher, B. Salzberger, N. Lehn, L. Naumann (Regensburg, Parsberg, Neustadt, Waldnaab, München-Gauting, Oberschleissheim, Germany)
| |